04/25/2024
8:05 AM | Kintara Therapeutics (Subject)
| Form 425 | |
04/25/2024
8:05 AM | Kintara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/03/2024
6:15 AM | Kintara Therapeutics (Subject)
| Form 425 | |
04/03/2024
6:09 AM | Kintara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/13/2024
6:00 AM | Kintara Therapeutics (Filer)
| Form RW | |
02/27/2024
5:59 AM | Kintara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/26/2024
6:00 AM | Kintara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
02/22/2024
6:00 AM | Kintara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/12/2024
8:05 AM | Kintara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/07/2023
8:10 AM | Kintara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/05/2023
8:10 AM | Kintara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/21/2023
6:55 AM | Kintara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/31/2023
7:10 AM | Kintara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/24/2023
3:43 PM | Kintara Therapeutics (Filer)
| Form S-1/A | |
10/04/2023
3:35 PM | Kintara Therapeutics (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
09/26/2023
3:09 PM | Kintara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/19/2023
3:20 PM | Kintara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/19/2023
3:16 PM | Kintara Therapeutics (Filer)
| Form 424B5 | |
09/18/2023
3:31 PM | Kintara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/18/2023
3:25 PM | Kintara Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
09/01/2023
5:00 PM | Brown Dennis M (Reporting)
Kintara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/01/2023
5:00 PM | Kintara Therapeutics (Issuer)
TOTH ROBERT JOSEPH JR (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/01/2023
5:00 PM | Hoffman Robert E. (Reporting)
Kintara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/01/2023
5:00 PM | FAVORITO TAMARA A (Reporting)
Kintara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/01/2023
5:00 PM | Johnson Laura L. (Reporting)
Kintara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/30/2023
4:11 PM | Kintara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/15/2023
2:31 PM | Kintara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/02/2023
7:30 AM | Kintara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/11/2023
7:01 AM | Kintara Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/11/2023
7:31 AM | Kintara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
